Using a manmade version of a human antibody to directly deliver a drug that inhibits a powerful driver of inflammation, can reverse a disease course that often leads to kidney failure and di... Read more
Human clinical trials could begin as early as next year A team of researchers at the University of Georgia’s Regenerative Bioscience Center and ArunA Biomedical, a UGA startup company, have... Read more
Scientists have developed a way to identify biomarkers for a wide range of diseases by assessing the antibodies we are making to the complex sugars coating our cells. Scientists have develop... Read more
Suppressing a protein builds muscle mass, improves markers of heart health without weight loss Suppressing production of the protein myostatin enhances muscle mass and leads to significant i... Read more
Simply replacing the connector in the IV system in patients with central lines could help reduce deadly bloodstream infections, researchers at Georgia Regents University have found. A centra... Read more